NEW YORK, July 13 (GenomeWeb News) - Shares in Transgenomic were up 22 percent, or $.17, at $.94 in late-afternoon trading after the company's CEO said the firm "should" reach neutral to positive operating cash flow by the end of the year.
Registering provides access to this and other free content.
Already have an account?Login Now.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.